ERBB2 and carcinoma: It has been previously reported that especially for E75 immunization protocols, E75 specific vaccine-induced CTLs failed to recognize HER-2+ tumors [73] and HLA-A2+-HER-2 overexpressing carcinomas, even after IFNγ treatment [74].